Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Freya Meds vs Oria Meds

By GLP-1 ScorecardUpdated

Freya MedsFactor scores not reassessed.
Site position #400

Lower score

Oria MedsFactor scores not reassessed.
Site position #272

Higher score

Score comparison

Oria Meds has the higher recorded score — 63.6/100 to 58.6/100.

Oria Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oria Meds' first-month prices give way to standing rates of $299 a month for semaglutide and $399 for tirzepatide.

Before you choose

Before comparing the headline prices, the Freya Meds review and the Oria Meds review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Freya Meds vs Prime Health and Hims vs Oria Meds compare each of them with another graded program, and the list of alternatives to Freya Meds ranks the programs closest to Freya Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Live Vital review covers one graded close to these two, at 62.7/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueOria Meds +11
43
54
Dose & formulationEven
64
64
Clinical oversightFreya Meds +6
71
65
Labs & monitoringFreya Meds +8
60
52
FulfillmentOria Meds +31
62
93
Contract termsOria Meds +12
55
67
Freya Meds · top barOria Meds · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFreya MedsOria Meds
WeighScore58.6/10063.6/100
GradeCC
Site position#400#272
Semaglutide$297/mo (compounded)$179 first month, then $299/mo ($249/mo renewal on 3-month plan; compounded)
Tirzepatide$390/mo (compounded)$279 first month, then $399/mo ($356/mo renewal on 3-month plan; compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Freya Meds

Site position #400 · C

Factor scores not reassessed.

Strengths

  • GLP-1 specialist — not a multi-category telehealth
  • Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
  • Both semaglutide and tirzepatide available
  • Multi-month discount on quarterly billing
  • Claims 450,000+ enrolled

What to consider

  • No visible LegitScript or PCAB accreditation
  • Above-average pricing ($250–$390/mo)
  • Compounded only — no brand-name options
  • Now serves 49 U.S. states (one state excluded; specific exclusion not named)
Oria Meds

Site position #272 · C

Factor scores not reassessed.

Strengths

  • Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
  • Free shipping and interest-free installments are offered at checkout
  • The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
  • Coverage is stated as all 50 states, subject to provider availability

What to consider

  • The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
  • Standing rates rose: semaglutide is $299 a month after a $179 first month (October: $199), and tirzepatide $399 after $279 (October: $369)
  • A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
  • Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
  • No legal entity, state of organization or governing law is published, and no clinician or NPI is named

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard